NOVAVAX INC: cash_and_equivalents
| Value | {"amount": 122493000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2013-09-30) |
| Status | current |
| Entity | NOVAVAX INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:41:02.413114+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/652415c9-1644-4ede-a54f-a1a320480445
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001144204-13-060509Retrieved: 2026-08-19T09:41:02.413114+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001000694/cash-and-equivalents/2013-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/652415c9-1644-4ede-a54f-a1a320480445
History
- no predecessors — first report